Steve Sosnick, Interactive Brokers’ chief strategist, discusses liquidity concerns in the current market.
Given the recent activity, risk management tools are something most investors are looking at more than usual.
Photo Credit: G. Starke via Flickr Creative Commons
Investors in pharmaceutical companies need to navigate the nuances of the drug discovery process, including FDA designations, patent cliffs, and generic competition to make informed investment decisions.
Markets wobbled following the FOMC’s decision to cut interest rates, and Chair Powell’s comments that the Fed may not adjust rates in December.
A handy list of finance and investment terms you should know.
He says he’s positioned to ride out a mediocre market in coming years.
